Skip to main content

Navigation group

Type at least 3 characters
628 articles

Articles

Clinical Trial

Published on 29 Sep 2023

Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

  • Jingxia Lv
  • Jiaxiang Wu
  • Haotian Wu
  • Ping’an Ding
  • Honghai Guo
  • Peigang Yang
  • Yuan Tian
  • Yang Liu
  • Qun Zhao
Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1201928
  • 2,134 views